Nikolay Davydenko Defends Jannik Sinner and Iga Swiatek Amid Doping Controversies
Former Russian tennis star Nikolay Davydenko has come to the defense of Jannik Sinner and Iga Swiatek following their involvement in doping controversies earlier this year. Both players, regarded among the best in the world, faced backlash despite their explanations for the presence of banned substances in their tests.
Jannik Sinner, the reigning men’s world No. 1, tested positive for Clostebol after two doping tests. However, he avoided a suspension after the International Tennis Integrity Agency (ITIA) accepted his explanation that the banned substance entered his system via a cream prescribed by a member of his coaching team to treat an injury.
Similarly, women’s world No. 2 Iga Swiatek tested positive for the banned substance trimetazidine and was handed a one-match suspension. These outcomes sparked criticism from sections of the tennis community, with calls for stricter and more consistent penalties in doping cases.
Davydenko, a former world No. 3 and two-time US Open semifinalist, defended the players, arguing that doping substances do not make someone a better tennis player. “You won’t become a better player by taking a pill. Tennis is tennis. You won’t become number one in the world thanks to doping,” Davydenko stated in a recent interview.
He highlighted the challenges athletes face when dealing with medications that might inadvertently contain banned substances. “You go to the pharmacy, take a pill for the bronchi, and there’s salbutamol, which is considered doping. You always have to go to a sports doctor—it’s such an absurdity.”
Davydenko also reflected on how the landscape of anti-doping regulations has changed since his playing days. “It used to be easier to regulate doping. We were also pressured, but we perceived it as normal. I didn’t worry much, I drank and ate everywhere without thinking about the possible consequences. Today, the situation has worsened.”
While the controversies surrounding Sinner and Swiatek have sparked debates about fairness in doping rulings, Davydenko’s remarks highlight the complexities athletes face in navigating anti-doping protocols in modern tennis.
